DRUG · Unmapped registry intervention
Gadoxetate Sodium
Find medicine records ·
Find other trials using this name
Clinical trial
Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer
NCT03960788
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedGadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: EARLY_PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Cancer of the Prostateunresolved
Castration-resistant Prostate Cancerunresolved
Interventions
Sponsors & collaborators
University of Cincinnatilead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03960788 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.